CRISPR/Cas13 could be used as broad anti viral for RNA viruses:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7985958/
https://www.genengnews.com/gen-edge...iosciences-uses-crispr-to-target-rna-viruses/
Dr Hanson and Dr Chia support the theory of chronic enterovirus non cytolytic infection as the driving mechanism in MECFS. This potential treatment would be worthy of consideration/investment.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7985958/
https://www.genengnews.com/gen-edge...iosciences-uses-crispr-to-target-rna-viruses/
Dr Hanson and Dr Chia support the theory of chronic enterovirus non cytolytic infection as the driving mechanism in MECFS. This potential treatment would be worthy of consideration/investment.
Last edited: